Deep Analysis of Impact of COVID-19 on “Mobile Stroke Unit (MSTU) Market 2012-2022” Growth Worldwide….
Global mobile
stroke unit market is expected
to reach USD 9.4million by 2022,
according to a new report by Grand View Research Inc.The demand for mobile
stroke unit is expected to upsurge owing to increasing demand for specialized emergency
rooms on wheel to increase the stroke survival rate.
With Covid-19 infections rising globally, the
apprehension regarding a shortage of essential life-saving devices and other
essential medical supplies in order to prevent the spread of this pandemic and
provide optimum care to the infected also widens. In addition, till a
pharmacological treatment is developed, ventilators act as a vital treatment
preference for the COVID-19 patients, who may require critical care. Moreover,
there is an urgent need for a rapid acceleration in the manufacturing process
for a wide range of test-kits (antibody tests, self-administered, and others).
The report will account for Covid19 as a key market contributor.
The incidence rate of stroke is high
owing to the lack of awareness amongpeople related to the primary stroke signs
and hence the government of developed economies such as the U.S. has
established many initiatives at the national level to address this issue. Some
of them are Act FAST, Stroke Training and Awareness Resources (STARS), stroke
program, and cryogenic stroke awareness.
Growing healthcare cost burden has
also increased the percentage of research funding for stroke. In April 2015,
the Health Economics Research Centre at Oxford University compared the research
spending for stroke from 2008 to 2012. The result established the fact that the
percentage of stroke research funding had increased from 1% to 3%. In 2012, the
government and charity spending for stroke in the UK was around USD 4.14
billion.
Stroke primarily occurs owing to
obesity, high blood pressure, cholesterol, and smoking habits. 87% of the
stroke is ischemic in nature due to the artery blockage in high blood pressure
patients. Obesity leads to difficulty in blood circulation as the body has high
fat.
To Request Sample Copy of this report, click the link:
Further key findings from the report
suggest:
·
The U.S. is the most potential
market owing to increasedstroke research funding and programs undertaken to
increase awareness and high penetration of telemedicine technology. In 2011,
the U.S. government spent over USD 302 million for stroke research to prevent
the primary signs of stroke such as atrial fibrillation and molecules discovery
to treat them. The January 2015 report released by the American Hospital
Association, surveyed that in 2013, 52% of hospitals used Telehealth, while 10%
implemented it. Consumers are willing to use the Telehealth services (74%)
highlighting the fact that telemedicine is highly adopted in the U.S.
·
Germany is another potential
market owing to the various research funds by the European Union to undertake
cardiac research in relation to atrial fibrillation. The ‘RETRAINER’ project
was supported by nine partners from Germany, Italy, Austria, and Switzerland.
In March 2003, German competence Network on Atrial Fibrillation (AFNET) was
formed to investigate the reason of arrhythmia and improving patient care. The
concept of mobilestroke unit originated from Germany, where the University of
Saarland placed a portable CT scanner in ambulance along with a
neurophysiologist to analyze the survival rate instroke patients. The concept
was then revolutionized and the world’s first MSU named STEMO came in to
existence.
·
The UK experiences around
152,000 stroke cases and an annual healthcare cost of USD 12.73 billion. The
increasing concern for the lack of stroke awareness led to the foundation of
the Act FAST campaign in February 2009. In February 2015, the NHS Lewisham
Clinical Commissioning Group and the Public Health England together supported
the Act FAST campaign highlighting the common signs of mini-strokes and
strokes. After the inception of this program, 38,600 people have additionally
gone to hospitals calling 999, the emergency number.
·
Manufacturers are also conducting
collaborative exercises to study the effect of pre-hospitalization treatment
against hospital stroke treatment. In July 2012, Neurologica Corporation and
Meytec partnered to develop world’s first comprehensive mobile stroke
ambulance. VIMED STEMO combines Meytec’s telemedicine technology with
Neurologica’s CT scanner. The state-of-the-art CereTomallows real time imaging,
thus reducing the treatment. To address increasing healthcare cost burden, the
European nation funded a robotic project to speed up stroke rehabilitation.
·
Some key
players of MSTUs market includeMeytec, Nueurologica Corporation, Excellance,
Frazer, and Falck.
A
Mobile Stroke Unit (MSU) includes advanced life support care ambulance
comprising CT scanner, a clot dissolving drug, i.e.,Tissue Plasminogen
Activator (tPA), and telemedicine technology. The Mobile Stroke
Unit market is expected to increase, owing to growing stroke incidence,
various awareness programs undertaken by the government organizations, and
research funds received by the research universities for better contribution
towards prevention, diagnosis, and treatment of stroke.
Every
year, around 15 million people have stroke, out of which six million die and
five million are left disabled permanently. This is largely owing to the lack
of awareness and recollecting the stroke warning signs. According to the
American Heart Association/American Stroke Association (AHA/ASA), one in three
Americans is unable to recall the warning signs of stroke.
In
February 2009, the UK launched the first stroke awareness campaign known as Act
Face, Arm,Speech,Time (F.A.S.T) by the Public Health England (PHE).
Thiscampaign increased alertness of people aboutthe common signs of stroke and
to call 999 (emergency number), if they observe such symptoms in them or
others. Realizing the success of this campaign, Act FAST was further adopted by
Australia and the U.S.
In
addition to increasing awareness, other factors that can control stroke are
keeping a check on blood pressure, cholesterol, and weight. According to the
AHA/ASA, around 87% of the incidents are ischemic in nature caused by clogged
or narrowing of blood vessels. Thus, regular checking of blood pressure and
controlling it is one of the preventive measures. In addition to this, obesity
is also a dominating factor. Around 60% Canadians are overweight and obese and
to stop this growing epidemic, the Heart and Stroke Foundation has launched the
Target Obesity initiative. Thisinitiative focusesonpreventing obesity by
improving nutrition and physical activitiesin Canada’s schools, communities,
and workplaces.
Have any Query? Ask our Experts:
Grand View Research has segmented the
global mobile stroke unitmarket on the basis of regions:
Mobile Stroke Unit Regional Outlook (Revenue, USD
Million, 2012 - 2022)
·
U.S.
·
UK
·
Germany
·
Argentina
Meytec,
Nueurologica Corporation, Excellance, Frazer, and Falck are few MSU market
players.In May 2012, NueroLogica and Meytec partnered to launch VIMED STEMO,
combining Neurologica CT scanner along with Meytec telemedicine technology.
Their combined competencies allow on-board physicians to quickly evaluate
patients and commence with the treatment within an hour after symptom onset.
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Comments
Post a Comment